Testosterone: Lessons Learned from TRAVERSE 2024

Androgen Society

Guidance on Optimal Candidates for Triplet Systemic Therapy in mHSPC…

Advanced Prostate Cancer Consensus Conference (APCCC)

N. James

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

SMSNA 2024 Insights: Exploring How BMI Shapes the Success of Inflata…

Muhammed Hammad

A Simple Approach to Prolonging Your Sexspan

Mohit Khera

Prostate Cancer - Risk Factors, Causes, and Screening Guidelines

Jim Hu

Review of Bladder Cancer Updates From ESMO 2024

The View on GU | with Lalani & Wallis

A. A. Lalani, C. Wallis

Total Therapy Considerations in Low-Volume mHSPC: Intensification vs…

Advanced Prostate Cancer Consensus Conference (APCCC)

O. Sartor

ESMO 2024 Insights: JCOG1019 Study - Watchful Waiting vs. Intravesic…

ecancer

H. Kitamura

ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC…

2024 ESMO Annual Meeting Insights Hub

C. Porta

SIU 2024 Insights: Partial Nephrectomy - Open, Laparoscopic or Robot…

Miguel Ramos

The Importance of Yearly Check-Ups for Men and Screening for Urologi…

Yale Cancer Center

M. Karellas

Improving QoL During and After Treatment in Prostate Cancer

Penn Medicine Abramson Cancer Center

C. Chow, R. Kovell

Recommended Imaging Standards for mHSPC in Daily Practice

Advanced Prostate Cancer Consensus Conference (APCCC)

M. Morris

No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Ph…

Dana-Farber Cancer Institute

B. McGregor

TRAVERSE Trial: Prostate Safety Events

Androgen Society

A. Morgentaler

Responding to Needs and Expectations of Patients with Erectile Dysfu…

European Society for Sexual Medicine

Y. Reisman

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

Controversies With Testosterone Replacement Therapy and Prostate Can…

Mohit Khera

Year in Review 2024 - Bladder Cancer

Oncology 2024 Year in Review

G. Sonpavde